Distribution of Twenty-Four Hour Urinary Taurine Excretion and Association with Ischemic Heart Disease Mortality in 24 Populations of 16 Countries: Results from the WHO-CARDIAC Study

There is considerable interest in the association between taurine (2-aminoethanesufonic acid) and risk of ischemic heart disease (IHD), but little information has been made available on the distribution of taurine in populations around the world. The present study aimed to describe the differences i...

Full description

Saved in:

Bibliographic Details
Published in:	Hypertension Research Vol. 24; no. 4; pp. 453 - 457
Main Authors:	YAMORI, Yukio, LIU, Longjian, IKEDA, Katsumi, MIURA, Ayako, MIZUSHIMA, Shunsaku, MIKI, Tomohiro, NARA, Yasuo, on Behalf of the WHO-Cardiovascular Disease and Alimentary Comparison (CARDIAC) Study Group
Format:	Journal Article
Language:	English
Published:	England The Japanese Society of Hypertension 01-07-2001
Subjects:	Circadian Rhythm Cross-Sectional Studies Databases as Topic Female Global Health Humans ischemic heart disease Male Middle Aged Myocardial Ischemia - mortality Myocardial Ischemia - urine Taurine - urine taurine distribution WHO-CARDIAC Study World Health Organization
Online Access:	Get full text
Tags:	Add Tag No Tags, Be the first to tag this record!

Description
Summary:	There is considerable interest in the association between taurine (2-aminoethanesufonic acid) and risk of ischemic heart disease (IHD), but little information has been made available on the distribution of taurine in populations around the world. The present study aimed to describe the differences in taurine excretion levels and their associations with IHD mortality rates in 24 populations in 16 countries worldwide. This was a multicenter cross-sectional study. In each center, 100 men and 100 women aged 48-56 years were selected randomly from the local populations. Twenty-four hour urinary taurine excretion was measured using an amino acid analyzer (Hitachi 835, Ibaragi, Japan). Age-adjusted IHD mortality rates in the relevant populations were calculated using the direct standard method. The results indicated that (a) percentiles 25%, 50% and 75% of the distributions of 24-h taurine excretion showed large variations in the study populations. Median values of taurine ranged from 191.6 μmol/day (St John, Canada) to 2,180.6 μmol/day (Beppu, Japan) in males, and from 127.5 μmol/day (Moscow, Russia) to 1,590.0 μmol/day (Beppu, Japan) in females. The highest overall median value of taurine was found in the Japanese population samples, followed by the Chinese samples (Shanghai and Taiwan). European, North American and oceanic Caucasians, however, had much lower median values of taurine, except in the cases of the samples from France and Spain. (b) Median values of taurine were significantly associated negatively with age-adjusted IHD mortality rates across the 24 study population samples in men (R2=0.42, p<0.01), and in women (R2=0.55, p<0.01). These negative associations remained significant after adjustment for serum total cholesterol, body mass index and urinary sodium to potassium ratios. In conclusion, the study provides, for the first time, a cross-sectional database on distribution of 24-h urinary taurine excretion in 24 population samples worldwide. A strong and inverse association between population levels of taurine excretion and IHD mortality was observed. (Hypertens Res 2001; 24: 453-457)
Bibliography:	ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23
ISSN:	0916-9636 1348-4214
DOI:	10.1291/hypres.24.453